# Radiolabeled Study of CC-220 in Healthy Male Subjects

> **NCT03294603** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** CC-220
- **RADIATION:** [14C]

## Key facts

- **NCT ID:** NCT03294603
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-11
- **Primary completion:** 2017-10-16
- **Final completion:** 2017-10-16
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03294603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03294603, "Radiolabeled Study of CC-220 in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03294603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*